To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Bk-MDEATemplate:DISPLAYTITLE:bk-MDEA Product highlight
beta-keto-MDEA, or 2-ethylamino-1-(3,4-methylenedioxyphenyl)propan-1-one, is the cathinone analogue of MDEA. It is reported to be less potent than methylone and has only a short history of human use.
|
||
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Bk-MDEA". A list of authors is available in Wikipedia. |
Last viewed
- BioNTech et Ryvu Therapeutics concluent un partenariat - Collaboration en matière de recherche pour plusieurs programmes d'immunothérapie par petites molécules
- Siemens plant Börsennotierung von Siemens Healthineers
- ZymoGenetics, Inc. - Seattle, Stati Uniti d'America
- The European Medicines Agency recommends Orphan Drug Designation of Intravenous CP-4126 for the Treatment of Pancreatic Cancer
- Bioartificial Human Liver Therapy Trial Progressing - Vital Therapies Enrolls First Patients in Expansion of its U.S. Clinical Trial in Europe
